Exhibit 10.29


 


PRIVATE
& CONFIDENTIAL


 


LEGALLY
BINDING TERM SHEET ON SHARE EXCHANGE TRANSACTION AMONG


DSS
SECURITY SYSTEMS INC., DSS BIOHEALTH SECURITY INC., GLOBAL BIOMEDICAL PTE LTD AND IMPACT BIOMEDICAL INC.


 


This
term sheet sets out the legally binding terms for transactions among the Parties as defined hereunder (“Term Sheet”).


 


	 

        PARTIES
	 

        1)     Document
        Security Systems, Inc., a New York corporation, having its office at 200 Canal View Blvd, Suite 300, Rochester, NY 14623.
        (hereinafter referred to as “DSS”)

         

        2)     DSS
        BioHealth Security Inc., a Delaware corporation, having its office at 200 Canal View Blvd, Suite 300, Rochester, NY 14623.
        (hereinafter referred to as “DBHS”)

         

        3)   Global
        BioMedical Pte Ltd, a Singapore corporation, company no. 201707501G having its office at 7 Temasek Boulevard #29-01B,
        Suntec Tower One, Singapore 038987. (hereinafter referred to as “GBM”)

         

        4)   Impact
        BioMedical Inc., a Nevada corporation, having its office at 4800 Montgomery Lane Suite 210 Bethesda, MD 20814. (hereinafter
        referred to as “IMPACT”)

         

        (DSS,
        DBHS and GBM, and IMPACT shall each be known as a “Party”, and collectively the “Parties”.)

         

	 

        TRANSACTION
        OVERVIEW
	 

GBM

                                                                                                        Owns
        100% of Impact Biomedical Inc. (“IMPACT”) Purchase Price: USD 50,000,000

         

        Proposed
        Share Exchange Transaction (“Share Exchange”) Between DSS and IMPACT

         

        In
        consideration of 100% of Impact, i.e. USD 50,000,000 (the “Consideration”, DSS will issue a combination
        of shares and perpetual convertible bond (PCB) as follows:

         

        -      USD
        3,132,000

         

        By
        way of issuing 14,500,000 shares at a price of USD 0.216 per share to GBM

         

        -      Balance
        of USD 46,868,000

         

        By
        way of PCB at 0% coupon rate per annum.

         



 


    	 		1│Page



     


    

 


	 	 


  Perpetual Convertible Bond
         

        -    0
        % Coupon Rate

        -    Conversion
        rate is at USD 0.216 per share

        -    GBM
        has right to convert the balance amount in PCB into DSS shares in full or
        partially, by giving 3 days written notice (at conversion rate of USD 0.216 in PCB to 1 DSS share)

        -    DSS
        has right to require GBM to convert the balance amount in PCB into DSS Shares in full or partially with 3 days written
        notice (at conversion rate of USD 0.216 in PCB to 1 DSS Share)

         

        The
        100% of IMPACT will be held under DBHS after the Share Exchange.

         

	 

        BLOCKER
	 

        It
        is agreed by Parties that GBM will not convert the PCB into DSS Shares to the extent where at any
        one point in time, GBM owns more than 19.9% of DSS.

         

	 

        VALUATION
	 

        DSS
        will appoint Destum Partners (an independent third-party professional valuation firm) to conduct an updated valuation
        report for IMPACT.

         

        The
        Parties agree that should the updated valuation report of IMPACT be higher than the agreed transaction value, GBM agrees
        to not increase the Consideration amount for IMPACT in the Share Exchange.

         

        The
        Parties further agree that should the updated valuation report of IMPACT be lower than the agreed transaction value, GBM
        agrees to lower the Consideration amount for IMPACT accordingly and offer the same 87.16% discount given to DSS for the
        Share Exchange.

         



 




    	 		2│Page



     


    

 


	 

        INITIAL
        PUBLIC OFFERING
	 

        It
        is the intention of IMPACT to pursue a public offering either on the New York Stock Exchange (NYSE) or Nasdaq, after the
        Share Exchange transaction.

         

	 

        DIVIDEND
        OF IMPACT SHARES
	 

        Upon
        the completion of the transaction, DBHS, which is a 100% owned subsidiary of DSS, will own 100% of IMPACT.

         

        It
        is the intention of DBHS, upon the completion of the Share Exchange, to offer bonus of IMPACT shares to the shareholders
        of DSS (excluding the controlling shareholders of DSS and the chairman’s group of companies). The proposed bonus
        being, for every one (1) DSS share held, the shareholder will be entitled to a bonus of two (2) shares of IMPACT as determined
        at the record date of the filing. (“Bonus Shares”). (“Bonus Shares”)

         

	 

        RIGHT
        TO APPOINT THE BOARD OF DIRECTORS OF IMPACT

         
	 

        DSS
        shall have the right to appoint the board of IMPACT.

         

	 

        REPRESENTATION
        AND WARRANTIES
	 

        The
        Parties hereby represent and warrant that they have on behalf of their respective companies, the full legal rights and
        capacities to enter into this Term Sheet and to perform their respective obligations and that they are not in violation
        of any laws or any courts.

         

        The
        Parties acknowledge that there may be fluctuations in the Share Price of DSS prior to the signing of this Term Sheet.

         

	 

        COUNTERPARTS
	 

        This
        Term Sheet and any amendments, if any, may be executed in counterparts (including by facsimile), each of which shall be
        an original with the same effect as if the signatures thereto and hereto were part of the same instrument and shall become
        effective when one or more counterparts have been signed by each of the Parties and delivered (by telecopy or otherwise)
        to the other Parties.

         



 


    	 		3│Page



     


    

 


	 

        CONFIDENTIALITY
	 

        Save
        for any disclosure, filing or report made to any government agency, regulatory body or exchange (including but not limited
        to the NYSE and SGX-ST), or disclosures made to accountants, advisors, legal
        counsel or consultants, each Party shall keep strictly confidential the negotiations relating to this transaction, the
        existence of this transaction and the contents of this Term Sheet and shall not disclose the name to any other person
        with the prior written consent of the other Parties.

         

	 

        BINDING
        EFFECT
	 

        This
        Term Sheet shall be legally binding and shall also be legally enforceable in accordance with its terms in any court of
        competent jurisdiction.

         

	 

        DEFINITIVE
        AGREEMENT
	 

        The
        Parties, if mutually agreeable and as soon as practicable and in any event, no later than three

        (3)
        months from date of signing of this Term Sheet, strive to obtain their respective directors and shareholders’ approvals;
        and relevant stock exchanges in which they are listed with, if required.

         

        The
        Parties may elect not to enter into a Definitive Agreement, in which event, the terms and conditions in this Term Sheet
        shall prevail and have full effects as if a definitive agreement has been entered into.

         

	 

        COMPLETION
	 

        Completion
        shall take place within three (3) months from the date of signing of this Term Sheet and subject to both DSS and
        GBM having obtained approvals from their respective shareholders and relevant stock exchanges in which they are
        listed with, if required for the transactions contemplated herein.

         

	 

        COSTS
        AND EXPENSES
	 

        Each
        Party shall be responsible for its respective costs and expenses in relation to the preparation of this Term Sheet and
        Definitive Agreement, if any.

         

	 

        GOVERNING
        LAW AND DISPUTE RESOLUTION
	 

        This
        Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to
        such state’s choice of law provisions which would require the application of the law of any other jurisdiction.

         



 


    	 		4│Page



     


    






 

Dated:


 


March 12, 2020


 


We
hereby accept the above terms and conditions.


 


	SIGNED
    BY:	 	SIGNED
    BY:
	 	 	 
	/s/
    Frank Heuszel	 	/s/
    Chan Heng Fai Ambrose
	Name:	FRANK
    HEUSZEL	 	Name:	CHAN
    HENG FAI AMBROSE
	Title:
    	Chief
    Executive Officer 	 	Title:	Chief
    Executive Officer 
	 	For
    and on behalf of DSS Securities Inc.	 	 	For
and on behalf of Global BioMedical Pte Ltd
	 	 	 	 	 
	/s/
    Frank Heuszel	 	/s/
    Chan Heng Fai Ambrose
	Name:	FRANK
    HEUSZEL	 	Name:	CHAN
    HENG FAI AMBROSE
	Title:
    	Chief
    Executive Officer 	 	Title:	Chief
    Executive Officer
	 	For
and on behalf of DSS BioHealth Security Inc.	 	 	For
    and on behalf of Impact Biomedical Inc.







 






    	 		5│Page